Massive loss of sulfur in HIV infection

AIDS Research and Human Retroviruses

Volumn 16, Issue 3, 2000, Pages 203-209

  Breitkreutz, Raoul ^a   Holm, Stefanie ^b   Pittack, Nicole ^b   Beichert, Matthias ^c   Babylon, Alexander ^a   Yodoi, Junji ^d   Dröge, Wulf ^a,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b I Medizinische Klinik   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KYOTO UNIVERSITY   (Japan)

^e Deutsches Kresbsforschungszentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; INTERLEUKIN 6; SULFUR; THIOREDOXIN; UREA;

ADULT; AMINO ACID ANALYSIS; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; SULFUR;

EID: 0034628626     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309296     Document Type: Article

References (25)

1. 1. Groß A, Hack V, Stahl-Hennig C, and Dröge W: Elevated hepatic γ-glutamylcysteine synthetase activity and abnormal sulfate levels in liver and muscle tissue may explain abnormal cysteine and glutathione levels in SIV-infected rhesus macaques. AIDS Res Hum Retroviruses 1996;12:1639-1641.
2. 2. Hack V, Gross A, Böhme A, Stahl-Hennig C, and Dröge W: Decrease in phosphocreatine level in skeletal muscle of SIV-infected rhesus macaques correlates with decrease in intracellular glutathione. AIDS Res Hum Retroviruses 1997;13:1089-1091.
3. 3. Dröge W, Eck H-P, Näher H, Pekar U, and Daniel V: Abnormal amino acid concentrations in the blood of patients with acquired immune deficiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe-Seyler 1988;369:143-148.
4. 4. Eck H-P, Gmünder H, Hartmann M, Petzoldt D, Daniel V, and Dröge W: Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe-Seyler 1989;370:101-108.
5. 5. Hortin GL, Landt M, and Powderly WG: Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem 1994;40:785-789.
6. 6. Huengsberg M, Waring R, Moffitt D, Round R, Winer J, Gompels M, and Shahmanesh M: Serum cysteine levels in HIV infection. AIDS 1998;12:1245-1259.
7. 7. Roederer M, Staal FJT, Osada H, Herzenberg LA, and Herzenberg LA: CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int Immunol 1991;3:933-937.
8. 8. Buhl R, Holroyd K, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB, Saltini C, and Crystal RG: Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; Dec 2: 1294-1298.
9. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 1995;86:258-267.
10. 10. Pirmohamed M, Williams D, Tingle MD, Barry M, Khoo SH, O'Mahony C, Wilkins EGL, Breckenridge AM, and Park BK: Intracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency. AIDS 1996;10:501-507.
11. 11. Hack V, Stütz O, Kinscherf R, Schykowski M, Kellerer M, Holm E, and Dröge W: Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J Mol Med 1996;74:337-343.
12. 12. Barbay K and Barbay P: Ein neuer Plethysmograph zur Messung der Extremitätendurchblutung. Z Kreislaufforsch 1963;52:1129-1140.
13. 13. De Vries BJ, Vitters E, Van den Berg WB, Schram D, and Van de Putte LBA: Determination of small quantities of sulfate (0-12 nmol) in serum, urine, and cartilage of the mouse. Anal Biochem 1987;163:408-417.
14. 14. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, and Herzenberg LA: Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996;8:603-611.
15. 15. Houssiau FA, Devogelaer JP, Van Damme J, De Deuxchaisnes CN, and Van Snick J: IL-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 1988;31:784-788.
16. 16. Lee HA and Hartley TF: A method of determining daily nitrogen requirements. Postgrad Med J 1975;51:441-445.
17. 17. Pantaleo G, Graziosi C, and Fauci AS: The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS 1993; 7(Suppl. 1):519-523.
18. 18. Marmor M, Alcabes P, Titus S, Frenkel K, Krasinski K, Penn A, and Pero RW: Low serum thiol levels predict shorter times-to-death among HIV-infected injecting drug users. AIDS 1997;11:1389-1393.
19. 19. Baldetorp L and Mårtensson J: Urinary excretion of inorganic sulfate, ester sulfate, total sulfur and taurine in cancer patients. Acta Med Scand 1980;208:293-295.
20. 20. Larsson J, Liljedahl S-O, Mårtensson J, Nordström H, Schildt B, and Sörbo B: Urinary excretion of sulfur amino acids and sulfur metabolites in burned patients receiving parenteral nutrition. J Trauma 1982;22:656-663.
21. 21. Mårtensson J, Larsson J, and Nordström H: Amino acid metabolism during the anabolic phase of severely burned patients: With special reference to sulphur amino acids. Eur J Clin Invest 1987;17:130-135.
22. 22. Mårtensson J, Denneberg T, Lindell Å, and Textorius O: Sulfur amino acid metabolism in cystinuria: A biochemical and clinical study of patients. Kidney Int 1990;37:143-149.
23. 23. Mårtensson J: The effects of short-term fasting on the excretion of sulfur compounds in healthy subjects. Metabolism 1982;31: 487-492.
24. 24. Cuthbertson DP: The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J 1931; 25:236-244.
25. 25. Webel DM and Baker DH: Cystine is the first limiting amino acid for utilization of endogenous amino acids in chicks fed a protein-free diet. Nutrition Res 1999;19:569-577.